The FDA granted "breakthrough" status to three promising experimental drugs as part of efforts to speed market entry for treatments of life-threatening conditions. "We expect many of these would come available very quickly with Phase I data," FDA Center for Drug Evaluation and Research Director Janet Woodcock said. Applications for breakthrough status have been made for 18 other treatments, she said.
Early trials may be enough for experimental drugs to get FDA OK
SmartBrief Job Listings for Health Care
|Commercial Health Insurance Strategist__Job #52-14||
American Academy of Family Physicians
|Manager of Payer Relations||
Pharmacy Quality Solutions, Inc.
|President/Chief Executive Officer||
|Consumer Directed Health Plan (CDH) Product Offering Manager||
Blue Cross Blue Shield MA
|Director, Payer Marketing||